AlzU Blog

Alzheimer’s Disease Information Discussed at the CTAD

Good news for professionals researchers for sharing Alzheimer’s disease information and prevention- The International Conference on Clinical Trials for Alzheimer’s Disease in Philadelphia, (also referred to as the CTAD), recently met to report the latest and greatest research showing the most promise for Alzheimer’s prevention and treatment interventions.

Since 2008 the CATD has put on an annual event initiated to allow the top AD researchers around the world to compare information on just what’s working best for the most promising Alzheimer’s prevention and treatment measures, according to clinical trials.

Alzheimer’s disease currently affects nearly 5.4 million individuals here in the U.S. and approximately 35 million people world-wide.  Those numbers are projected to increase to 115 million if intervention measures are not identified before the year 2050. 

This year, many experts in the AD field gathered together in order to share the latest Alzheimer’s disease information regarding which clinical trials are showing the best results for future treatment for mild to moderate Alzheimer’s disease.

Paul Aisen, MD, University of California at San Diego; Bruno Vellas, MD, University of Toulouse; Jacques Touchon, MD, University of Montpellier;  and Michael Weiner, MD, University of California at San Francisco chaired the convention this year.

“As evidenced by the research being presented this year, efforts to develop effective treatments for Alzheimer’s disease have been focused on the earliest stages of the disease, before symptoms are even apparent—but the needs of people already diagnosed have not been forgotten,” said the director of the Alzheimer’s Disease Cooperative Study (and Co-Organizer of the CTAD Conference), Paul Aisen, MD. 

Three categories were identified and discussed at this year’s conference, including:
Preventing Alzheimer’s by Treating Early
New Treatment Strategies for Mild to Moderate AD
Treating the Most Troubling Symptoms in AD

Read more about findings discussed at the conference by reading subsequent caregiver blogs on AlzU.org, and be sure to sign up for our 25 lessons on AlzU.org by CLICKING HERE.

Why Join?

Alzheimer's Universe has been created by medical experts to help learn the latest about AD diagnosis, treatment & prevention

Sign Up

Prevention & Treatment

Learn about the latest tips used to help reduce AD risk, delay onset of symptoms, and how to manage AD using a comprehensive approach

Join Now

Learn More

Click on the button below to learn about why Alzheimer's Universe was created, how it works, and what to expect after joining

Learn More

As Seen On:

The Today Show CNN.com

Share AlzU.org with friends and family: